1 completed, 1 not yet recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
Follow Jing Luo: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s GLP-1 dose reduction, non-GLP weight loss medication, Maintenance of GLP-1 dose - Obesity & Overweight, Cardiometabolic Health Indicators | Phase 4 | Not yet recruiting | Jing Luo | 60 | 2026-11-01 | 2026-10-05 |
| Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings Insulin Glargine, NPH or premixed 70/30 (human insulin) - Diabetes Mellitus, Type 1, Type 1 Diabetes | Phase 4 | Completed | Jing Luo | 400 | 2023-03-15 | 2025-09-10 |
Diabetes Mellitus, Type 1 (1) · Insulin Resistance (1) · Obesity (1) · Overweight (1)
Insulin (1) · Insulin Glargine (1)
Bangladesh (1) · Tanzania (1) · United States (1)
R01DK148666 (1)